|
|||||
|
|

Packaged foods company Conagra Brands (NYSE:CAG) met Wall Streets revenue expectations in Q4 CY2025, but sales fell by 6.8% year on year to $2.98 billion. Its non-GAAP profit of $0.45 per share was 3.2% above analysts’ consensus estimates.
Is now the time to buy CAG? Find out in our full research report (it’s free for active Edge members).
Conagra’s fourth quarter was marked by weaker sales volumes and a significant drop in operating margin, with the market reacting negatively to the results. Management attributed the year-over-year sales decline to persistent supply constraints in frozen foods, delayed seasonal demand, and a competitive promotional environment. CEO Sean Connolly noted that, “Our goal this quarter in Frozen was to reclaim the market share that we basically loaned out to a competitor when we had supply constraints beginning last winter.” The company also faced continued inflationary pressures in key protein inputs, which weighed on profitability.
Looking ahead, management is focused on driving organic sales growth in the second half of the year through renewed promotional activity, innovation, and improved supply chain resiliency. Connolly emphasized, “We absolutely expect margin expansion going forward, particularly in frozen, and the building blocks have not changed.” The company’s ongoing Project Catalyst, which aims to automate core business processes and enhance efficiency, is expected to contribute to long-term margin recovery. Management remains cautious given the volatile environment but maintains its outlook for adjusted earnings as it executes on these strategic priorities.
Conagra’s leadership pointed to several operational and market factors driving quarterly results and shaping the path forward.
Conagra’s outlook is anchored in efforts to restore volume growth, expand margins, and strengthen operational efficiency amid a volatile backdrop.
In the quarters ahead, the StockStory team will be closely watching (1) the pace of volume recovery in frozen and snacks as supply and merchandising normalize, (2) the effectiveness of Project Catalyst in delivering tangible margin and efficiency gains, and (3) the ability to offset input cost pressures through productivity and innovation. Ongoing competitive pricing dynamics and consumer health trends will also remain key areas of focus.
Conagra currently trades at $17.38, down from $17.80 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free for active Edge members).
If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.
Don’t wait for the next volatility shock. Check out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
| Dec-22 | |
| Dec-21 | |
| Dec-21 | |
| Dec-20 | |
| Dec-19 | |
| Dec-19 | |
| Dec-19 | |
| Dec-19 | |
| Dec-19 | |
| Dec-19 | |
| Dec-19 | |
| Dec-19 | |
| Dec-19 | |
| Dec-19 | |
| Dec-19 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite